102 related articles for article (PubMed ID: 36309672)
1. Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.
Kim DG; Yoo JW; Koo KC; Chung BH; Lee KS
BMC Urol; 2022 Oct; 22(1):164. PubMed ID: 36309672
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study.
Yoo JW; Lee KS
Prostate Int; 2022 Mar; 10(1):28-33. PubMed ID: 35510098
[TBL] [Abstract][Full Text] [Related]
3. Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?
Koparal MY; Sözen TS; Karşiyakali N; Akdoğan B; Özen H; Aslan G; Türkeri L
Arch Esp Urol; 2022 Jun; 75(5):410-415. PubMed ID: 35983811
[TBL] [Abstract][Full Text] [Related]
4. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
5. The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy.
Kilic M; Madendere S; Vural M; Koseoglu E; Balbay MD; Esen T
World J Urol; 2023 Feb; 41(2):449-454. PubMed ID: 36595078
[TBL] [Abstract][Full Text] [Related]
6. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC
J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918
[TBL] [Abstract][Full Text] [Related]
7. The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy.
Patel N; Cricco-Lizza E; Kasabwala K; Xu C; Robinson BD; Khani F; Wang Y; Margolis D; Hu JC
Eur Urol Oncol; 2018 Sep; 1(4):263-267. PubMed ID: 31100246
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.
Lee KS; Koo KC; Chung BH
World J Urol; 2018 Jul; 36(7):1059-1065. PubMed ID: 29508049
[TBL] [Abstract][Full Text] [Related]
9. Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
Apfelbeck M; Pfitzinger P; Bischoff R; Rath L; Buchner A; Mumm JN; Schlenker B; Stief CG; Chaloupka M; Clevert DA
Clin Hemorheol Microcirc; 2020; 76(4):503-511. PubMed ID: 33337358
[TBL] [Abstract][Full Text] [Related]
10. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Aneja S; Syed JS; Pahade J; Mathur M; Sprenkle P; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 May; 210(5):W218-W225. PubMed ID: 29489409
[TBL] [Abstract][Full Text] [Related]
11. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate.
Hsieh PF; Chang TY; Lin WC; Chang H; Chang CH; Huang CP; Yang CR; Chen WC; Chang YH; Wang YD; Huang WC; Wu HC
BMC Urol; 2022 Apr; 22(1):72. PubMed ID: 35488246
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate.
Shin T; Smyth TB; Ukimura O; Ahmadi N; de Castro Abreu AL; Ohe C; Oishi M; Mimata H; Gill IS
BJU Int; 2018 Jan; 121(1):77-83. PubMed ID: 28749070
[TBL] [Abstract][Full Text] [Related]
17. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
18. Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score.
Martorana E; Pirola GM; Scialpi M; Micali S; Iseppi A; Bonetti LR; Kaleci S; Torricelli P; Bianchi G
BJU Int; 2017 Jul; 120(1):92-103. PubMed ID: 27608292
[TBL] [Abstract][Full Text] [Related]
19. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
20. Cognitive versus Software-Assisted Registration: Development of a New Nomogram Predicting Prostate Cancer at MRI-Targeted Biopsies.
Kaufmann S; Russo GI; Thaiss W; Notohamiprodjo M; Bamberg F; Bedke J; Morgia G; Nikolaou K; Stenzl A; Kruck S
Clin Genitourin Cancer; 2018 Aug; 16(4):e953-e960. PubMed ID: 29685613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
